Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays

Annals of Pharmacotherapy

Volumn 39, Issue 9, 2005, Pages 1446-1449

  Caravati, E Martin ^a,b   Juenke, JoEtta M ^c   Crouch, Barbara I ^a,d   Anderson, Kathleen T ^a,d  

^a Utah Poison Control Center   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ARUP LABORATORIES   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

False positive; Quetiapine; Toxicology screen; Tricyclic antidepressant immunoassay

Indexed keywords

CARBAMAZEPINE; CYCLOBENZAPRINE; CYPROHEPTADINE; DIPHENHYDRAMINE; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; QUETIAPINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; AUTOANALYZER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG CROSS REACTIVITY; DRUG METABOLISM; DRUG OVERDOSE; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IN VITRO STUDY; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE DIAGNOSIS; TOXICOLOGICAL PARAMETERS; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIPSYCHOTIC AGENTS; CROSS REACTIONS; DIBENZOTHIAZEPINES; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FALSE POSITIVE REACTIONS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOASSAY; INDICATORS AND REAGENTS;

EID: 23944523310     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G107     Document Type: Article

References (14)

1. Mahoney JD, Gross PL, Stern TA, Browne BJ, Pollack MH, Reder V, et al. Quantitative serum toxic screening in the management of suspected drug overdose. Am J Emerg Med 1990;8:16-22.
2. Wu AH, McKay C, Broussard LA, Hoffman RS, Kwong TC, Moyer TP, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department. Clin Chem 2003;49:357-79.
3. Fisher J. Immunoassay drug screen results: easy to get, hard to interpret. J Toxicol Clin Toxicol 1998;36:115-6.
4. Chattergoon DS, Verie Z, Anderson M, Johnson D, McGuigan MA, Koren G, et al. Carbamazepine interference with an immune assay for tricyclic antidepressants in plasma. J Toxicol Clin Toxicol 1998;36:109-13.
5. Sorisky A, Watson DC. Positive diphenhydramine interference in the EMIT-st assay for tricyclic drugs and their metabolites in plasma (letter). Clin Chem 1986;32:715.
6. Poklis A, Edinboro LE, Lee JS, Crooks CR. Evaluation of a colloidal metal immunoassay device for the detection of tricyclic antidepressants in urine. J Toxicol Clin Toxicol 1997;35:77-82.
7. Wians FH, Norton JT, Wirebaugh SR. False positive serum tricyclic antidepressant screen with cyproheptadine. Clin Chem 1003;38:1355-6.
8. Benitez J, Dahlqvist R, Gustafsson LL, Magnusson A, Sjoqvist F. Clinical pharmacological evaluation of an assay kit for intoxications with tricyclic antidepressants. Ther Drug Monit 1986;8:102-5.
9. Hendrickson RG, Morocco AP. Quetiapine cross reactivity among three tricyclic antidepressant immunoassays. J Toxicol Clin Toxicol 2003;41: 105-8.
10. DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine. Clin Pharmacokinet 2001;40:509-22.
11. Balit CR, Isbister GK, Hackett LP, Whyte IM. Quetiapine poisoning: a case series. Ann Emerg Med 2003;42:751-8.
12. Schussler JM, Juenke JM, Schussler I. Quetiapine and falsely elevated nortriptyline level (letter). Am J Psychiatry 2003;160:589.
13. Sloan KL, Haver VM, Saxon AJ. Quetiapine and false positive urine drug testing for tricyclic antidepressants (letter). Am J Psychiatry 2000; 157:148-9.
14. Al-Mateen CS, Wolf CE II. Falsely elevated imipramine levels in a patient taking quetiapine (letter). J Am Acad Child Adolesc Psychiatry 2002;41:5-6.